Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source. 



DoD Breast Cancer Research Program Funding Opportunities

Applications to the FY18 BCRP are being solicited for the DHA. The BCRP supports innovative, high-impact research focused on ending breast cancer. 

• Breakthrough Award Level 1 & 2: Supports promising research that has the potential to lead to or make breakthroughs in breast cancer. LOI Due: November 1, 2018



Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01/R21)

The purpose of this FOA is to support basic research examining how Electronic Nicotine Delivery Systems (ENDS) aerosols affect normal and disease states relevant to human cells, tissues and organs.

Application Deadline: October 24, 2018


NCCN/Eli Lilly and Company Quality of Care in Gastric Cancer Request for Proposals

NCCN® and Eli Lilly are collaborating to offer a new opportunity seeking proposals to bridge the gaps in care for gastric and gastroesophageal junction (GEJ) cancer patients in the United States.

Letter of Intent Due: October 24, 2018



Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01/R21)

The purpose of this FOA is to support studies on electronic nicotine delivery systems (ENDS) that examine population-based, clinical and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, benefits and impacts on other tobacco use behavior among different populations.

Application Deadline: October 24, 2018



Tobacco Use and HIV in Low and Middle Income Countries (R01)

The purpose of this FOA is to encourage research focused on tobacco use and HIV infection in low and middle income countries.

Application Deadline: November 1, 2018



NCI Outstanding Investigator Award

This FOA invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research.

Application Deadline: November 2, 2018
 

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01)

This  FOA calls for interdisciplinary collaborations across scientific  disciplines engaged in microbiome and pro/prebiotic research. 

Application Deadline: November 5, 2018


Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)

This FOA encourages innovative research to enhance the quality of measurements of dietary intake and physical activity.

Application Deadline: November 5, 2018



The Role of Epitranscriptomics in Development and Disease 

The purpose of this FOA is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. 

Application Deadline: November 7, 2018

 

Feasibility Studies to Build Collaborative Partnerships in Cancer Research

This FOA invites P20 planning grant applications for developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students and NCI- designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs)

Application Deadline: November 14, 2018



Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers

The purpose of this FOA is to facilitate the design, conduct, and completion of clinical trials for improving prevention of human papillomavirus (HPV)-related cancers in HIV-infected individuals.

Application Deadline: November 15, 2018



Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center

Through this FOA, the NCI proposes and will support the Cancer Prevention Clinical Trials Network (CP-CTNet).

Application Deadline: November 15, 2018

Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)

This FOA encourages innovative research to enhance the quality of measurements of dietary intake and physical activity.

Application Deadline: November 16, 2018

https://grants.nih.gov/grants/guide/pa-files/PAR-18-857.html



Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine

The purpose of this FOA is to invite Cooperative Agreement applications to develop research resources that will encourage a consensus on how Quantitative Imaging (QI) methods are optimized to improve the quality of imaging results for co-clinical trials.

Application Deadline: November 19, 2018

https://grants.nih.gov/grants/guide/pa-files/PAR-18-841.html 


Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)

The purpose of this FOA is to promote the discovery of strong candidate biomarkers and endpoints  for pain that can be used to facilitate the development of non-opioid  pain therapeutics from discovery through Phase II clinical trials. 

Application Deadline: November 27, 2018


Analytical and/or Clinical Validation of a Candidate Biomarker for Pain

The overarching purpose of FOA is to promote the validation of strong candidate biomarkers and endpoints for pain that can be used to facilitate the development of non-opioid pain therapeutics from discovery through Phase II clinical trials.

Application Deadline: November 27, 2018



Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21/R01)

This R21 NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of pain target discovery and validation projects

Application Deadline: November 27, 2018


Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium

This FOA, issued by the NCI, is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research.

Application Deadline: December 7, 2018


Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network

The purpose of this administrative supplement is to support a strengthening of community outreach capacity by working through the National Outreach Network (NON).

Application Deadline: December 15, 2018



Administrative Supplements to Cancer Center Support Grants to Strengthen the Research, Training, and Outreach Capacity of the Geographic Management of Cancer Health Disparities Program

Through this FOA, the NCI intends to: support seven region-based “hubs” or networks to facilitate underrepresented investigator/trainee recruitment and career/professional development; provide enhanced capacity in the area of cancer health disparities research; and promote CHD research-related infrastructure development and evaluation.

Application Deadline: December 17, 2018



Pediatric Immunotherapy Discovery and Development Network (PI-DDN) (U54 and U01)

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended  to accelerate cancer research. The purpose is to establish centers of collaborating investigators with the goal of identifying and  advancing research opportunities for translating immunotherapy concepts  for children and adolescents with cancer toward clinical applications.

Application Deadline: December 17, 2018

 
Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) 

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended  to accelerate cancer research. The purpose is to increase case ascertainment and appropriate follow-up care, optimizing the  delivery of evidence-based healthcare for individuals at high risk of  cancer due to an inherited genetic susceptibility. 

Application Deadline: January 9, 2019 

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-017.html 

Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)

This FOA is to provide a mechanism of support to research organizations interested in clinically translating already optimized quantitative imaging software tools capable of measuring or predicting the response of cancer to clinical therapies, or in translating imaging tools for planning and validating radiation therapy treatment strategies in clinical trials.

Application Deadline: January 9, 2019


Communication and Decision Making for Individuals with Inherited Cancer Syndromes

This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose is to develop, test, and evaluate interventions and implementation approaches, or adapt existing approaches, to improve patient/provider/family risk communication and decision making for individuals and families with an inherited susceptibility to cancer.

Application Deadline: January 9, 2018


Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)

This FOA is to provide a mechanism of support to research organizations interested in clinically translating already optimized quantitative imaging software tools capable of measuring or predicting the response of cancer to clinical therapies, or in translating imaging tools for planning and validating radiation therapy treatment strategies in clinical trials.

Application Deadline: January 9, 2019


NCI Research Specialist Award (R50)

This award encourages the development of stable research career opportunities for exceptional scientists who want to pursue research within the context of an existing cancer research program, but not serve as independent investigators.

Application Deadline: January 11, 2019

https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/r50


NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)

This FOA invites grant applications for the Research  Specialist Award (R50) in any area of NCI-funded cancer research. 

Application Deadline: January 11, 2019



NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

Through this FOA, the NCI invites grant applications for the Research Specialist Award (R50) in  any area of NCI-funded cancer research. 

Application Deadline: January 11, 2019


 

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research

This FOA encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.

Application Deadline: February 11, 2019



The NCI Predoctoral to Postdoctoral Fellow Transition Award

The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers.

Application Deadline: February 22, 2019

The Yale Cancer Center Internal Grant Program aims to provide funds for innovative, high quality start-up cancer research programs and provide new investigators with experience and guidance in the grant-writing process. 

The criteria for funding is high quality, innovative cancer research with a likelihood to result in NIH-funded cancer research and encourage collaborations within YCC. Grant competitions will be announced in DirectConnect and will undergo an anonymous NIH-style peer review with written reviews provided to applicants.  

Women’s Health Research at Yale Pilot Project Grants

On behalf of Dr. Carolyn M. Mazure and WHRY, we are pleased to announce the availability of Pilot Project Grants with awards starting July 1, 2019. All Yale Ladder Faculty are eligible to apply. Investigators outside the Yale community are invited to collaborate with Yale or Yale-affiliated principal investigators.

Letter of Intent Due: October 25, 2018



Nominations for Annual YCC Awards

Yale Cancer Center is pleased to announce our call for nominations for our annual awards in the areas of excellence in research and clinical care. Research Prizes will be awarded in support of excellence in the areas of basic science, clinical research, translational research, and cancer prevention and control. To be eligible you must be either the first or last author of the publication. Email your publication to anna.raso@yale.edu

Nomination Deadline: October 26th, 2018

2019 Szent-Gyorgyi Prize for Progress in Cancer Research

The Prize was established to honor an outstanding researcher whose  scientific achievements have expanded our understanding of cancer and  cancer causation. Nominations may be made by individuals from the research community, industry, government, or other organizations who are sufficiently familiar with the research  accomplishments and contributions of the nominee.

Internal Application Deadline: September 20, 2018
Sponsor Nomination Deadline: September 30, 2018

https://yalecancercenter.submittable.com/submit/5e4d6700-193a-4e7c-9fe3-22fe77ddab99/2019-szent-gyorgyi-prize-for-progress-in-cancer-research

Applications for the Yale Cancer Center K12 Calabresi Immuno-Oncology Training Program (IOTP) Scholar Awards

We are pleased to solicit applications for the Yale Cancer Center (YCC) K12 Calabresi Immuno-Oncology Training Program (IOTP) Scholar Award for junior faculty to enhance research skills beyond the training provided during graduate and postgraduate training. Successful applicants are required to demonstrate a strong commitment to a career in cancer immunology.  The two-year IOTP curriculum includes didactic and practical training in basic, translational and clinical aspects of cancer immunology research. The program also includes a required research component (either clinical or bench research, or a combination thereof). Applicants will be funded for up to 75% effort and can receive up to $27,800 per year for research expenses. Applicants are required to identify a mentor and a provide a research and mentorship proposal. For additional information and questions, please contact Meina Wang, PhD (meina.wang@yale.edu) or Harriet Kluger, MD (harriet.kluger@yale.edu).
 
Application Deadline: December 1, 2018 at 5:00 PM EST



The NCI Predoctoral to Postdoctoral Fellow Transition Award

The purpose of this Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers.

Internal Deadline: December 13, 2018


Luminary Award of Excellence

The YNHH Smilow Luminary Award of Excellence will serve to recognize, and ceremoniously acknowledge, those individuals and/or teams who consistently exceed performance expectations and deliver high quality cancer care for our patients, families and the health system through community service, optimization/ innovative solutions, patient experience, leadership and research initiatives. Nominations should be submitted directly to Luminary@ynhh.org